Solid Biosciences upgraded by Leerink Partners with a new price target
$SLDB
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Leerink Partners upgraded Solid Biosciences from Market Perform to Outperform and set a new price target of $12.00